DENTSPLY SIRONA Inc. ( XRAY ) NASDAQ Global Select

Cena: 11.27 ( -0.02% )

Aktualizacja 12-05 21:53
NASDAQ Global Select
Branża: Medycyna - Instrumenty i Zaopatrzenie


symbol 1D 5D 1M 3M 6M YTD 1Y 3Y 5Y 10Y
XRAY -0.2 0.8 2.1 -23.1 -29.4 -40.0 -41.0 -62.6 -79.0 -82.1
Notowania:

Opis firmy:

Dentsply Sirona Inc. produkuje różne produkty i technologie dentystyczne dla profesjonalnego rynku dentystycznego na całym świecie. Firma działa w dwóch segmentach, technologiach i sprzęcie oraz materiałach eksploatacyjnych. Segment technologii i sprzętu zapewnia sprzęt dentystyczny, takich jak centra zabiegowe, sprzęt do obrazowania, motoryzowane rękodzieło dentystyczne i inne instrumenty dla lekarzy dentystycznych i specjalistów; Technologie dentystyczne CAD/CAM dla biur dentystycznych w celu obsługi różnych cyfrowych zabiegów dentystycznych, w tym uzupełnień dentystycznych; kierowane przez dentystę roztwory wyrównującego, Suresmile i bezpośrednio do konsumenta, a także urządzenie technologii wibracji o wysokiej częstotliwości; implanty; oraz cewniki urologii i inne produkty konsumpcyjne związane z opieką zdrowotną. Segment materiałów eksploatacyjnych oferuje produkty endodontyczne zawierające ćwiczenia, filtry, uszczelniacze, igły igły nawadniające oraz inne narzędzia lub rozwiązania jednorazowe, które obsługują procedury kanału korzeniowego; Produkty odbudowujące, w tym sztuczne zęby, ceramikę dentystyczną, protezy cyfrowe, stopy dentystyczne metali szlachetnych oraz produkty porcelanowe koron i mostu. Zapewnia również produkty małych wyposażenia, które obejmują wewnątrzustne systemy światła utwardzania, systemy diagnostyczne dentystyczne oraz skalery i polerki ultradźwiękowe, a także środki znieczulające dentystyczne, pastę profilaktyki, uszczelniaczy dentystyczne, materiały do ​​wrażenia, białaweczki zębów i fluorowy fluor. Firma została założona w 1877 roku i ma siedzibę w Charlotte w Karolinie Północnej.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medycyna - Instrumenty i Zaopatrzenie
Zatrudnienie: 15 000
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 99.0919
Ilość akcji: Brak danych
Debiut giełdowy: 1987-08-12
WWW: https://www.dentsplysirona.com
CEO: Mr. Simon D. Campion
Adres: 13320 Ballantyne Corporate Place
Siedziba: 28277-3607 Charlotte
ISIN: US24906P1093
Wskaźniki finansowe
Kapitalizacja (USD) 2 248 451 811
Aktywa: 5 753 000 000
Cena: 11.27
Wskaźnik Altman Z-Score: 0.74
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 1
P/E: -2.6
Ilość akcji w obrocie: 99%
Średni wolumen: 3 502 857
Ilość akcji 199 551 969
Wskaźniki finansowe
Przychody TTM 3 671 000 000
Zobowiązania: 3 810 000 000
Przedział 52 tyg.: 9.85 - 20.6
Piotroski F-Score:
EPS: -4.4
P/E branży: 29.7
Beta: 1.027
Raport okresowy: 2026-02-26
WWW: https://www.dentsplysirona.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Simon D. Campion Chief Executive Officer, President & Director 2 452 393 1972
Mr. Robert Anthony Johnson Senior Vice President & Chief Supply Chain Officer and Head of Sustainability 1 565 721 1969
Mr. Andreas G. Frank Executive Vice President & Chief Business Officer 1 372 374 1976
Mr. Glenn G. Coleman Executive Vice President & Chief Financial Officer 1 259 178 1968
Mr. Richard C. Rosenzweig Executive Vice President, General Counsel & Secretary 1 219 120 1967
Ms. Erania S. Brackett Senior Vice President of Orthodontic Aligner Solutions & Customer Experience 0 1974
Mr. Richard M. Wagner Chief Accounting Officer 0 1968
Andrea Daley Vice President of Investor Relations 0 0
Ms. Andrea L. Frohning Senior Vice President & Chief Human Resources Officer 0 1970
Mr. Kevin Boyle Senior Vice President & Chief Technology Officer 0 0
Lista ETF z ekspozycją na akcje DENTSPLY SIRONA Inc.
Symbol ETF Ilość akcji Wartość
VCSH 15 638 000 14 510 793
BND 11 472 000 10 645 083
VTI 6 350 302 80 077 308
VTS.AX 6 350 302 80 077 308
XMH.TO 6 341 390 245 098
IJH.AX 6 341 390 330 033
IJH 6 341 390 67 091 906
XUU.TO 6 341 390 139 247
XMC.TO 6 341 390 392 426
XAW.TO 6 341 390 84 604
VRP 4 855 000 4 575 724
VB 4 703 451 59 310 517
BSV 4 691 000 4 352 866
BSCU 4 407 000 4 044 211
VBR 3 023 492 38 126 234
IHHY.AX 2 225 000 285 400
VXF 2 127 743 26 830 839
IHHG.L 1 992 223 16 082 299
XCNS.TO 1 914 944 3 608
XINC.TO 1 914 944 1 074
XGRO.TO 1 914 944 59 373
XBAL.TO 1 914 944 34 214
IHYE.L 1 752 642 16 082 299
IBC2.DE 1 752 642 16 082 299
IHYU.L 1 520 066 16 082 299
IS0R.DE 1 520 066 13 948 178
IHYU.MI 1 520 066 13 948 178
SHYU.L 1 520 066 12 270 794
IHYA.L 1 520 066 16 082 299
MDY 1 468 400 14 697 801
IJJ 1 054 938 11 161 244
SCYB 1 005 000 946 579
SCHA 959 130 9 763 617
SPMD 924 237 9 140 744
SIHY 799 000 751 904
VYM 781 006 9 848 485
IWR 726 144 7 682 603
VHT 601 378 7 583 376
DFAS 585 185 5 787 479
DES 543 324 5 748 367
IWD 448 702 4 747 267
BINC 441 815 4 674 406
RDIV 401 641 4 249 361
IHYF 400 000 376 990
SMLF 386 010 4 083 985
KOMP 354 917 3 510 125
FNDX 343 922 3 457 593
MDYV 321 561 3 185 811
BBHY 321 000 302 149
SCHZ 315 000 289 341
AVSC 306 868 3 034 924
XHY.TO 300 000 405 964
SP5C.PA 298 427 2 590 754
LYSPH.SW 298 427 2 412 640
6TVM.DE 298 427 2 590 754
SP5G.L 298 427 2 278 439
SP5C.L 298 427 2 986 207
SP5L.L 298 427 2 278 439
LSPX.L 298 427 227 843 922
SP5H.PA 298 427 2 590 754
LSPU.L 298 427 2 986 207
LYP2.DE 298 427 2 590 754
SPHC.MI 298 427 2 590 754
LYPS.DE 298 427 2 590 754
ETFSP500.WA 298 427 10 976 120
IVOO 295 294 3 723 657
IWS 293 597 3 106 256
BBAG 281 000 257 794
ITOT 265 944 2 813 687
XEQT.TO 265 944 180 233
GHYG.L 263 694 2 128 680
XBB 255 000 244 484
HYLC.SW 249 014 2 128 680
HYLE.DE 231 983 2 128 680
DFAT 219 958 2 175 384
SCHJ 215 000 197 313
BSMC 203 274 2 150 638
HYLA.L 201 199 2 128 680
IBC9.DE 201 199 1 846 204
HYLD.L 201 199 2 128 680
IGHY.L 201 199 1 624 183
DHYG.L 177 912 1 436 199
XHE 172 675 1 734 000
GPRF 172 000 174 407
IUSV 168 775 1 785 639
DHYC.SW 168 007 1 436 199
IVOV 160 503 2 023 942
LCTU 159 235 1 684 706
UEEF.DE 156 516 1 436 199
WLDS.L 151 075 1 219 558
IUSN.DE 151 075 1 386 269
WSML.L 151 075 1 598 373
IWB 144 725 1 531 190
VT 140 052 1 766 055
DHYA.L 135 747 1 436 199
DHYD.AS 135 747 1 436 199
DHYE.AS 135 747 1 245 616
VFVA 128 771 1 634 103
DHS 121 128 1 281 534
PRF 120 357 1 273 377
IYH 119 521 1 264 532
RWK 118 393 1 252 597
SCHB 116 566 1 165 583
HYSD.L 110 882 895 102
VONV 107 908 1 360 719
XHYH 105 000 100 669
VBND.AX 100 000 141 790
IHCB.AX 100 000 7 072
FHLC 84 715 1 177 538
HYUS.L 84 603 895 102
HYUS.SW 84 603 895 102
JHSC 82 261 829 190
PFIG 80 000 73 414
SUOP.L 76 724 619 355
RECS 75 670 800 588
EZM 75 612 799 974
ESML 73 892 781 777
36BA.DE 67 497 619 355
BBSC 65 827 696 449
CSUSS.MI 63 731 584 797
CUS1.L 63 731 514 471
CUSS.L 63 731 674 273
SXRG.DE 63 731 584 797
ONEQ 63 730 885 847
VVLU.AX 62 706 1 200 663
36BE.DE 58 540 537 166
SUOA.AS 58 540 619 355
SUOU.AS 58 540 619 355
5UOA.DE 58 540 537 166
SMMD 58 133 615 047
VFQY 57 272 726 781
ONEY 56 934 563 077
IWV 54 562 577 265
DFAC 47 830 473 038
VISM.AX 46 012 886 292
ESGV 43 743 551 599
EQAL 43 442 459 616
SPTM 41 442 409 910
ISCV 40 186 425 167
VVL.TO 39 289 693 720
AVUS 36 320 359 204
DFUS 33 074 327 101
DSI 32 705 346 018
VONE 30 983 390 695
OMFL 30 934 327 281
TILT 28 490 301 424
SMLV 27 737 274 320
QVMM 26 775 283 279
DFAU 26 764 264 695
PTMC 24 914 263 590
XJH 23 871 252 555
AGBP.L 23 110 186 552
IUGA.L 21 376 172 561
FELV 20 829 289 523
EUNA.DE 20 330 186 552
JPME 19 020 201 231
IUAE.L 18 806 172 561
AGUG.AS 17 633 186 552
AGGU.L 17 633 186 552
AGGG.L 17 633 186 552
EUNU.DE 17 633 161 797
EUNX.DE 16 310 149 662
SUAG.L 16 310 131 664
IUAG.L 16 310 172 561
IUAA.L 16 310 172 561
DTD 16 176 171 142
GHYS.L 15 849 127 941
GHYC.SW 15 838 135 387
DHSF.MI 15 359 162 498
WTDY.DE 15 359 162 498
DHSA.L 15 359 162 498
DHSG.L 15 359 162 498
DHSP.L 15 359 162 498
WTEU.DE 15 359 162 498
WTD9.DE 15 359 162 498
DHSD.L 15 359 162 498
DHS.L 15 359 162 498
VTHR 15 339 193 424
FNDB 15 185 152 823
VFMF 13 302 168 802
ONEV 12 197 120 630
HEJD 11 824 125 097
CRHG.L 11 555 93 276
CORC.SW 10 912 93 276
36B7.DE 10 165 93 276
DFSU 9 065 89 652
ISCB 8 935 94 532
VLU 8 932 87 669
CRPS.L 8 816 71 169
IS0X.DE 8 816 80 898
CORP.L 8 816 93 276
CRPU.L 8 816 93 276
CRPA.L 8 816 93 276
PAMC 8 623 91 231
DXUV 8 429 83 362
DEW 7 325 77 498
MVV 6 887 72 864
STXK 6 329 63 796
AEGG.L 5 777 46 638
SHIR.SW 5 456 46 638
ICBU.L 5 378 56 898
SXRF.DE 5 378 49 348
AEGE.MI 5 083 46 638
V3AM.L 4 439 42 709
V3AL.L 4 439 55 975
V3AB.L 4 439 42 709
V3AA.L 4 439 55 975
AGGD.AS 4 408 46 638
AGGE.AS 4 408 46 638
QQQS 3 767 39 854
REVS 3 240 34 279
BBCB 3 000 2 752
MIDU 2 828 27 968
MFUS 2 643 27 962
GVUS 2 557 42 369
R1VL.L 2 536 26 830
AVSU 2 258 22 331
JUST 2 157 35 741
XUH.TO 1 394 14 751
CBUG.DE 1 363 12 506
EWSA.AS 1 363 14 420
UMDD 1 223 12 939
STXV 882 8 890
GVLU 519 0
ONEO 434 4 292
XTR.TO 325 38 187
MIDE 314 3 322
SPDG 68 672
XSE.TO 47 4 325
MMTM 42 414
XSC.TO 33 2 983
XSI.TO 4 326
6PSA.DE 0 0
PXS.TO 0 5 931
PSWD.DE 0 0
GTR 0 318 020
PSRF.L 0 0
PSRW.L 0 0
PRUS.L 0 0
DWSH -10 836 -114 644
CRDT -13 179 -139 431
CDX -94 591 -1 000 775
QIS -204 118 -2 159 566
Wiadomości dla DENTSPLY SIRONA Inc.
Tytuł Treść Źródło Aktualizacja Link
Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Shareholders to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / May 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-05-15 14:00:00 Czytaj oryginał (ang.)
XRAY or COO: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Dentsply International (XRAY) and The Cooper Companies (COO). But which of these two stocks presents investors with the better value opportunity right now? zacks.com 2025-05-14 16:45:46 Czytaj oryginał (ang.)
Is Dentsply Sirona (XRAY) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-05-14 14:45:59 Czytaj oryginał (ang.)
Here's Why Dentsply International (XRAY) is a Strong Value Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com 2025-05-14 14:41:28 Czytaj oryginał (ang.)
Dentsply (XRAY) Reliance on International Sales: What Investors Need to Know Evaluate Dentsply's (XRAY) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance. zacks.com 2025-05-13 14:21:37 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / May 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-05-11 14:00:00 Czytaj oryginał (ang.)
Dentsply Sirona Stock Is Rallying The Most Since 2019 on Thursday – What's Driving It? Dentsply Sirona Inc. XRAY stock surged about 15% Thursday, and was on track for the biggest single-day advance since 2019 after posting earnings that topped estimates. benzinga.com 2025-05-08 17:31:15 Czytaj oryginał (ang.)
XRAY Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down DENTSPLY SIRONA's customer-centric innovation and operational efficiency drive its first-quarter 2025 performance despite global macroeconomic challenges. zacks.com 2025-05-08 16:55:32 Czytaj oryginał (ang.)
Dentsply (XRAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2025-05-08 14:36:11 Czytaj oryginał (ang.)
DENTSPLY SIRONA Inc. (XRAY) Q1 2025 Earnings Call Transcript DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President, Investor Relations Simon Campion - Chief Executive Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Partners Dylan Finley - UBS David Saxon - Needham & Company Jon Block - Stifel Jeff Johnson - Baird Jason Bednar - Piper Sandler Brandon Vazquez - William Blair Erin Wright - Morgan Stanley Operator Welcome to the Q1 2025 Dentsply Sirona Earnings Conference Call. At this time, all participants are in a listen-only mode. seekingalpha.com 2025-05-08 14:04:39 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-05-08 14:00:00 Czytaj oryginał (ang.)
Dentsply International (XRAY) Surpasses Q1 Earnings and Revenue Estimates Dentsply International (XRAY) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.42 per share a year ago. zacks.com 2025-05-08 12:11:07 Czytaj oryginał (ang.)
Dentsply Sirona Reports First Quarter 2025 Results CHARLOTTE, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2025. globenewswire.com 2025-05-08 10:00:00 Czytaj oryginał (ang.)
Stay Ahead of the Game With Dentsply (XRAY) Q1 Earnings: Wall Street's Insights on Key Metrics Get a deeper insight into the potential performance of Dentsply (XRAY) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. zacks.com 2025-05-07 14:21:16 Czytaj oryginał (ang.)
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / May 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-05-06 14:00:00 Czytaj oryginał (ang.)
DENTSPLY SIRONA to Post Q1 Earnings: What's in Store for the Stock? XRAY is likely to have faced a tough first quarter with Byte's revenue loss, weak U.S. equipment demands and implant pressures. zacks.com 2025-05-05 16:15:40 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect NEW YORK CITY, NY / ACCESS Newswire / May 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-05-04 14:00:00 Czytaj oryginał (ang.)
Earnings Preview: Dentsply International (XRAY) Q1 Earnings Expected to Decline Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2025-05-01 15:06:13 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation NEW YORK CITY, NY / ACCESS Newswire / May 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-05-01 14:00:00 Czytaj oryginał (ang.)
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-04-29 14:00:00 Czytaj oryginał (ang.)
DENTSPLY SIRONA Inc. (XRAY) Q4 2024 Earnings Call Transcript DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Andrea Daley - Vice President of Investor Relations Simon Campion - President & Chief Executive Officer Herman Cueto - Interim Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore ISI Erin Wright - Morgan Stanley Brandon Vazquez - William Blair David Saxon - Needham & Company Jeffrey Johnson - Baird Kevin Caliendo - UBS Michael Cherny - Leerink Partners Jonathan Block - Stifel Jason Bednar - Piper Sandler Operator Good day and thank you for standing by. Welcome to the Q4 2024 DENTSPLY SIRONA Earnings Conference Call. seekingalpha.com 2025-02-27 18:01:03 Czytaj oryginał (ang.)
XRAY Q4 Earnings & Revenues Miss Estimates, Gross Margin Down DENTSPLY SIRONA's fourth-quarter results showcase dismal segmental performance with declining adjusted operating income. zacks.com 2025-02-27 13:31:17 Czytaj oryginał (ang.)
Dentsply International (XRAY) Misses Q4 Earnings and Revenue Estimates Dentsply International (XRAY) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.44 per share a year ago. zacks.com 2025-02-27 10:10:37 Czytaj oryginał (ang.)
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year of 2024. globenewswire.com 2025-02-27 08:00:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-02-26 12:00:00 Czytaj oryginał (ang.)
Dentsply (XRAY) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates Evaluate the expected performance of Dentsply (XRAY) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com 2025-02-25 12:20:42 Czytaj oryginał (ang.)
DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock? XRAY is likely to have faced a tough fourth quarter with Byte's revenue loss, weak U.S. equipment demand and implant pressures. zacks.com 2025-02-24 17:00:32 Czytaj oryginał (ang.)
Earnings Preview: Dentsply International (XRAY) Q4 Earnings Expected to Decline Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2025-02-20 13:06:11 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-02-19 12:00:00 Czytaj oryginał (ang.)
XRAY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Dentsply Sirona Inc. and Encourages Investors to Contact the Firm NEW YORK, NY / ACCESS Newswire / February 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-02-16 12:00:00 Czytaj oryginał (ang.)
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating DENTSPLY SIRONA Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DENTSPLY SIRONA Inc. (NASDAQ:XRAY) on behalf of long-term stockholders following a class action complaint that was filed against Dentsply on November 26, 2024 with a Class Period from May 6, 2021 to November 6, 2024. Our investigation concerns whether the board of directors of Dentsply have breached their fiduciary duties to the company. globenewswire.com 2025-02-13 23:00:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-02-12 12:00:00 Czytaj oryginał (ang.)
Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business (“Wellspect”). globenewswire.com 2025-02-11 10:30:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Connect NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-02-09 12:00:00 Czytaj oryginał (ang.)
Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Michael J. Barber and Daniel T. Scavilla have been appointed to its Board of Directors (the “Board”), effective February 5, 2025. globenewswire.com 2025-02-06 10:30:00 Czytaj oryginał (ang.)
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-02-05 12:00:00 Czytaj oryginał (ang.)
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation NEW YORK, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY. accessnewswire.com 2025-02-02 12:00:00 Czytaj oryginał (ang.)
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating DENTSPLY SIRONA Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DENTSPLY SIRONA Inc. (NASDAQ:XRAY) on behalf of long-term stockholders following a class action complaint that was filed against Dentsply on November 26, 2024 with a Class Period from May 6, 2021 to November 6, 2024. Our investigation concerns whether the board of directors of Dentsply have breached their fiduciary duties to the company. globenewswire.com 2025-01-29 23:00:00 Czytaj oryginał (ang.)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DENTSPLY SIRONA Inc. - XRAY NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ: XRAY).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. prnewswire.com 2025-01-28 13:20:00 Czytaj oryginał (ang.)
Lost Money on Dentsply Sirona Inc. (XRAY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=125427&wire=1 or contact Joseph E. Levi, Esq. accessnewswire.com 2025-01-27 18:30:00 Czytaj oryginał (ang.)
Contact Levi & Korsinsky by January 27, 2025 Deadline to Join Class Action Against Dentsply Sirona Inc.(XRAY) NEW YORK, NY / ACCESSWIRE / January 4, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120634&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-04 20:01:00 Czytaj oryginał (ang.)
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against DENTSPLY SIRONA Inc LOS ANGELES, CA / ACCESSWIRE / January 4, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 1, 2022 and November 6, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before January 27, 2025. accesswire.com 2025-01-04 13:15:00 Czytaj oryginał (ang.)
Class Action Announcement for DENTSPLY SIRONA Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against DENTSPLY SIRONA Inc. - Contact Kessler Topaz Meltzer & Check, LLP RADNOR, Pa., Jan. 03, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed in the United States District Court for the Southern District of New York against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQ: XRAY) on behalf of those who purchased or otherwise acquired DENTSPLY common stock between May 6, 2021, and November 6, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 27, 2025. globenewswire.com 2025-01-03 22:53:00 Czytaj oryginał (ang.)
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XRAY NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between February 28, 2022 and November 6, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline. globenewswire.com 2025-01-03 22:33:00 Czytaj oryginał (ang.)
Dentsply Sirona Inc. Class Action: Levi & Korsinsky Reminds Dentsply Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025 – XRAY NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120586&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-03 18:30:00 Czytaj oryginał (ang.)
XRAY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dentsply Sirona Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) and certain of its officers. globenewswire.com 2025-01-03 18:00:00 Czytaj oryginał (ang.)
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Dentsply Sirona Inc. (XRAY) Shareholders NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120563&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-03 17:15:00 Czytaj oryginał (ang.)
Lowey Dannenberg Notifies Dentsply Sirona Inc. (“Dentsply Sirona,” “Dentsply,” or the “Company”) (NASDAQ: XRAY) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm NEW YORK, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Dentsply Sirona Inc. (“Dentsply Sirona,” “Dentsply,” or the “Company”) (NASDAQ: XRAY) for violations of the federal securities laws on behalf of investors who purchased or acquired Dentsply Sirona common stock between December 1, 2022 and November 6 2024, inclusive (the “Class Period”). globenewswire.com 2025-01-03 16:48:00 Czytaj oryginał (ang.)
January 27, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against XRAY NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120537&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-03 14:30:00 Czytaj oryginał (ang.)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in DENTSPLY SIRONA Inc. of Class Action Lawsuit and Upcoming Deadlines - XRAY Pomerantz LLP announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. ("Dentsply" or the "Company") (NASDAQ:XRAY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. accesswire.com 2025-01-03 14:00:00 Czytaj oryginał (ang.)
Lost Money on Dentsply Sirona Inc. (XRAY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120504&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-03 13:45:00 Czytaj oryginał (ang.)
DENTSPLY SIRONA Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm LOS ANGELES, CA / ACCESSWIRE / January 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between December 1, 2022 and November 6, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before January 27, 2025. accesswire.com 2025-01-03 13:30:00 Czytaj oryginał (ang.)
Kirby McInerney LLP Urges Investors in Dentsply Sirona Inc. (XRAY) to Inquire About Their Rights in Class Action Lawsuit NEW YORK--(BUSINESS WIRE)---- $XRAY #CLASSACTIONLAWSUIT--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Dentsply Sirona Inc. (“Dentsply” or the “Company”) (NASDAQ:XRAY) securities between May 6, 2021, through and including November 6, 2024 (“the Class Period”). Investors have until January 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit. [LEARN MO. businesswire.com 2025-01-03 10:00:00 Czytaj oryginał (ang.)
Class Action Filed Against Dentsply Sirona Inc. (XRAY) Seeking Recovery for Investors - Contact Levi & Korsinsky NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120406&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-03 09:30:00 Czytaj oryginał (ang.)
XRAY Stockholders Have Opportunity to Lead Dentsply Sirona Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! NEW YORK CITY, NY / ACCESSWIRE / January 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Dentsply securities between May 6, 2021, and November 06, 2024, both dates inclusive (the "Class Period"). accesswire.com 2025-01-03 09:00:00 Czytaj oryginał (ang.)
Levi & Korsinsky Reminds Dentsply Sirona Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025 - XRAY NEW YORK, NY / ACCESSWIRE / January 3, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120388&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-03 08:48:00 Czytaj oryginał (ang.)
Dentsply Sirona Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights - XRAY NEW YORK , Jan. 3, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Dentsply investors who were adversely affected by alleged securities fraud between May 6, 2021 and November 6, 2024. prnewswire.com 2025-01-03 07:45:00 Czytaj oryginał (ang.)
XRAY LAWSUIT ALERT: Levi & Korsinsky Notifies Dentsply Sirona Inc. Investors of a Class Action Lawsuit and Upcoming Deadline NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120346&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-02 20:45:00 Czytaj oryginał (ang.)
XRAY Investors Have Opportunity to Lead Dentsply Sirona Inc. Securities Fraud Lawsuit NEW YORK , Jan. 2, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between May 6, 2021 and November 6, 2024, both dates inclusive (the "Class Period"), of the important January 27, 2025 lead plaintiff deadline. So what: If you purchased Dentsply Sirona common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. prnewswire.com 2025-01-02 20:00:00 Czytaj oryginał (ang.)
Dentsply Sirona Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights - XRAY NEW YORK, NY / ACCESSWIRE / January 2, 2025 / If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dentsply-lawsuit-submission-form?prid=120245&wire=1 or contact Joseph E. Levi, Esq. accesswire.com 2025-01-02 15:45:00 Czytaj oryginał (ang.)